Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer

Abstract Background The low level of circulating tumor DNA (ctDNA) in the blood is a well-known challenge for the application of liquid biopsies in early-stage non-small cell lung cancer (NSCLC) management. Studies of metastatic NSCLC indicate that ctDNA levels are associated with tumor metabolic ac...

Full description

Bibliographic Details
Main Authors: Anine Larsen Ottestad, Håkon Johansen, Tarje Onsøien Halvorsen, Hong Yan Dai, Sissel Gyrid Freim Wahl, Elisabeth Fritzke Emdal, Bjørn Henning Grønberg
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Cancer
Subjects:
18F-FDG PET/CT
Circulating tumor DNA
Non-small cell lung cancer
Glucose metabolism
Liquid biopsy
Online Access:https://doi.org/10.1186/s12885-023-11147-z

Internet

https://doi.org/10.1186/s12885-023-11147-z

Similar Items